118 related articles for article (PubMed ID: 9174292)
1. Aprotinin but not tranexamic acid inhibits cytokine-induced inducible nitric oxide synthase expression.
Hill GE; Robbins RA
Anesth Analg; 1997 Jun; 84(6):1198-202. PubMed ID: 9174292
[TBL] [Abstract][Full Text] [Related]
2. Differing effects of aprotinin and epsilon-aminocaproic acid on cytokine-induced inducible nitric oxide synthase expression.
Hill GE; Taylor JA; Robbins RA
Ann Thorac Surg; 1997 Jan; 63(1):74-7. PubMed ID: 8993244
[TBL] [Abstract][Full Text] [Related]
3. Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass.
Hill GE; Springall DR; Robbins RA
Surgery; 1997 Apr; 121(4):449-55. PubMed ID: 9122876
[TBL] [Abstract][Full Text] [Related]
4. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
[TBL] [Abstract][Full Text] [Related]
5. Aprotinin reduces nitric oxide production in vitro and in vivo in a dose-dependent manner.
Bruda NL; Hurlbert BJ; Hill GE
Clin Sci (Lond); 1998 May; 94(5):505-9. PubMed ID: 9682673
[TBL] [Abstract][Full Text] [Related]
6. N-alpha-tosyl-L-lysine chloromethylketone prevents expression of iNOS in vascular smooth muscle by blocking activation of NF-kappa B.
Schini-Kerth VB; Boese M; Busse R; Fisslthaler B; Mülsch A
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):672-9. PubMed ID: 9108779
[TBL] [Abstract][Full Text] [Related]
7. Effects of aprotinin or tranexamic acid on proteolytic/cytokine profiles in infants after cardiac surgery.
Hsia TY; McQuinn TC; Mukherjee R; Deardorff RL; Squires JE; Stroud RE; Crawford FA; Bradley SM; Reeves ST; Spinale FG
Ann Thorac Surg; 2010 Jun; 89(6):1843-52; discussion 1852. PubMed ID: 20494037
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29.
Kolios G; Brown Z; Robson RL; Robertson DA; Westwick J
Br J Pharmacol; 1995 Dec; 116(7):2866-72. PubMed ID: 8680718
[TBL] [Abstract][Full Text] [Related]
9. The effect of aprotinin on ischemia-reperfusion injury in the rabbit kidney.
Ozer Z; Sucu N; Düşmez D; Tamer L; Altunkan AA; DIkmengIl M; Oral U
Pharmacol Res; 2001 Dec; 44(6):455-60. PubMed ID: 11735350
[TBL] [Abstract][Full Text] [Related]
10. Heparin-binding EGF-like growth factor down regulates proinflammatory cytokine-induced nitric oxide and inducible nitric oxide synthase production in intestinal epithelial cells.
Lara-Marquez ML; Mehta V; Michalsky MP; Fleming JB; Besner GE
Nitric Oxide; 2002 Mar; 6(2):142-52. PubMed ID: 11890738
[TBL] [Abstract][Full Text] [Related]
11. Serine and cysteine proteinase inhibitors prevent nitric oxide production by activated macrophages by interfering with transcription of the inducible NO synthase gene.
Griscavage JM; Wilk S; Ignarro LJ
Biochem Biophys Res Commun; 1995 Oct; 215(2):721-9. PubMed ID: 7488014
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-induced nitric oxide formation in normal but not in neoplastic murine lung epithelial cell lines.
Thompson DC; Porter SE; Bauer AK; Das KC; Ou B; Dwyer-Nield L; White CW; Malkinson AM
Am J Physiol; 1998 Jun; 274(6):L922-32. PubMed ID: 9609731
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate inhibition of inducible nitric oxide synthase in murine lung epithelial cells in vitro.
Robbins RA; Jinkins PA; Bryan TW; Prado SC; Milligan SA
Am J Respir Cell Mol Biol; 1998 Jun; 18(6):853-9. PubMed ID: 9618390
[TBL] [Abstract][Full Text] [Related]
14. Effects of tranexamic acid and aprotinin on PAF-induced vascular permeability in normal, thrombocytopenic or neutropenic rats.
O'Brien JG; Farmer P; Battistini B; Johnson RJ; Zaharia F; Sirois P
Inflamm Res; 1997 Aug; 46 Suppl 2():S145-6. PubMed ID: 9297553
[No Abstract] [Full Text] [Related]
15. Endothelin-1 inhibits the expression of inducible nitric oxide synthase.
Markewitz BA; Michael JR; Kohan DE
Am J Physiol; 1997 Jun; 272(6 Pt 1):L1078-83. PubMed ID: 9227507
[TBL] [Abstract][Full Text] [Related]
16. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
[TBL] [Abstract][Full Text] [Related]
17. Expression of inducible nitric oxide in human lung epithelial cells.
Robbins RA; Barnes PJ; Springall DR; Warren JB; Kwon OJ; Buttery LD; Wilson AJ; Geller DA; Polak JM
Biochem Biophys Res Commun; 1994 Aug; 203(1):209-18. PubMed ID: 7521161
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycosylation end products induce inducible nitric oxide synthase (iNOS) expression via a p38 MAPK-dependent pathway.
Chang PC; Chen TH; Chang CJ; Hou CC; Chan P; Lee HM
Kidney Int; 2004 May; 65(5):1664-75. PubMed ID: 15086905
[TBL] [Abstract][Full Text] [Related]
19. Coordinated induction of inducible nitric oxide synthase and GTP-cyclohydrolase I is dependent on inflammatory cytokines and interferon-gamma in HaCaT keratinocytes: implications for the model of cutaneous wound repair.
Frank S; Kolb N; Werner ER; Pfeilschifter J
J Invest Dermatol; 1998 Dec; 111(6):1065-71. PubMed ID: 9856818
[TBL] [Abstract][Full Text] [Related]
20. The effects of lidocaine on nitric oxide production from an activated murine macrophage cell line.
Shiga M; Nishina K; Mikawa K; Obara H
Anesth Analg; 2001 Jan; 92(1):128-33. PubMed ID: 11133614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
